Released Aug 9, 2016, after the close
10-Q filed Aug 9, 2016, 40 days after period end · 0001144204-16-117669
Q2 2016 · 10-Q
Revenue—
Net Income-$10.15M-$10.15M N/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$0.59-$0.59 N/M vs Q2 2015N/M vs Q1 2016
Operating Income-$10,454,130N/M
Operating Cash Flowderived-$6,767,707N/M
Free Cash Flowderived-$6,767,707N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | -$10.15M | -$6.94M | -$2.47M | -$4.75M |
| EPS Diluted | -$0.59 | -$0.41 | -$0.52 | -$1.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR